Why Vanda Pharmaceuticals Stock Sank by Nearly 6% Today The Motley Fool A regulator’s decision drained the market’s enthusiasm for the company. Biotech Nasdaq 100 Pharmaceuticals S&P 500 3 hours
This S&P 500 Stock Falls On Earnings Despite Expected Tailwind From Fed Rate Cuts Investor's Business Daily 4 hours
Nvidia Stock Is Surging Today — Time to Invest in the Artificial Intelligence (AI) Leader? The Motley Fool 5 hours
S&P 500 Soars On First Fed Rate Cut; Here’s How Much Stocks May Rally Investor's Business Daily 6 hours
Nvidia’s stock is surging. Here’s how it tends to perform after interest-rate cuts. MarketWatch 8 hours
Is Micron Stock the Next Artificial Intelligence (AI) Winner? Unfortunately, Analysts Say No The Motley Fool 11 hours
Nvidia and Other Artificial Intelligence Semiconductor Stocks Got Amazing News From OpenAI The Motley Fool 11 hours
Analyst on Broadcom Inc (AVGO): Ignore ‘Minor Bump in the Road’ and Buy the Dip Insider Monkey 11 hours
Nvidia’s CEO Has Sold Shares Virtually Every Trading Session Since Mid-June. Should Investors Follow Suit and Sell? The Motley Fool 12 hours
Is the Vanguard S&P 500 ETF Still a Great Investment Even With the Stock Market at an All-Time High? The Motley Fool 12 hours
Wedbush’s Dan Ives Says Microsoft (MSFT) Is One of the Top Stocks for AI Revolution Insider Monkey 12 hours
If You’d Invested $10,000 in AMD Stock 10 Years Ago, Here’s How Much You’d Have Today The Motley Fool 12 hours
This Nvidia ETF Has a Sky-High 77% Dividend Yield, but Should You Just Buy Nvidia Stock Instead? The Motley Fool 13 hours
GeneDx Stock Rocketed 1310% In Dramatic Turnaround Powered By DNA Analytics Investor's Business Daily 13 hours
Aurinia Pharmaceuticals: LUPKYNIS Leading The Way In Lupus Nephritis Treatment Seeking Alpha 13 hours